These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
941 related articles for article (PubMed ID: 1967191)
1. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191 [TBL] [Abstract][Full Text] [Related]
2. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. Dis Markers; 1990; 8(3):164-5. PubMed ID: 2125538 [No Abstract] [Full Text] [Related]
3. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection]. Antón F; Labarga P; Pinilla J; Soto MJ; Leoz A; del Cura J; Borque L; Milazzo A Enferm Infecc Microbiol Clin; 1993; 11(7):373-7. PubMed ID: 8104488 [TBL] [Abstract][Full Text] [Related]
4. HLA class I soluble antigen serum levels in HIV-positive subjects--correlation with cellular and serological parameters. Puppo F; Orlandini A; Ruzzenenti R; Comuzio S; Salamito A; Farinelli A; Stagnaro R; Indiveri F Cancer Detect Prev; 1990; 14(3):321-3. PubMed ID: 2117484 [TBL] [Abstract][Full Text] [Related]
5. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers. Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977 [TBL] [Abstract][Full Text] [Related]
6. [Serum neopterin and beta2-microglobulin concentration as "prognostic markers" of AIDS]. Halota W; Jaruga B; Pawłowska M Pol Merkur Lekarski; 2002 Aug; 13(74):126-8. PubMed ID: 12420343 [TBL] [Abstract][Full Text] [Related]
7. Surrogate markers for AIDS treatment. Jacobson M Nurs Times; 1991 May 29-Jun 4; 87(22):49. PubMed ID: 1675013 [No Abstract] [Full Text] [Related]
8. Immune activation markers and AIDS prognosis. Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808 [TBL] [Abstract][Full Text] [Related]
9. Use of beta 2-microglobulin level and CD4 lymphocyte count to predict development of acquired immunodeficiency syndrome in persons with human immunodeficiency virus infection. Anderson RE; Lang W; Shiboski S; Royce R; Jewell N; Winkelstein W Arch Intern Med; 1990 Jan; 150(1):73-7. PubMed ID: 1967523 [TBL] [Abstract][Full Text] [Related]
10. Improvement of the predictive value of CD4+ lymphocyte count by beta 2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate. The Multicentre Cohort Study Group. Schwartländer B; Bek B; Skarabis H; Koch J; Burkowitz J; Koch MA AIDS; 1993 Jun; 7(6):813-21. PubMed ID: 8103341 [TBL] [Abstract][Full Text] [Related]
11. Serum beta 2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T-cell fall and prognosis. Hofmann B; Wang YX; Cumberland WG; Detels R; Bozorgmehri M; Fahey JL AIDS; 1990 Mar; 4(3):207-14. PubMed ID: 1972020 [TBL] [Abstract][Full Text] [Related]
12. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific. Krämer A; Biggar RJ; Hampl H; Friedman RM; Fuchs D; Wachter H; Goedert JJ Am J Epidemiol; 1992 Jul; 136(1):71-80. PubMed ID: 1384311 [TBL] [Abstract][Full Text] [Related]
13. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I. AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100 [TBL] [Abstract][Full Text] [Related]
14. The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels. Sheppard HW; Lang W; Ascher MS; Vittinghoff E; Winkelstein W AIDS; 1993 Sep; 7(9):1159-66. PubMed ID: 8105806 [TBL] [Abstract][Full Text] [Related]
15. [Study on serum neopterin concentration in hemophiliacs with anti-human immunodeficiency-virus type I antibody]. Matsuda J Rinsho Byori; 1991 Jul; 39(7):743-7. PubMed ID: 1920867 [TBL] [Abstract][Full Text] [Related]
16. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine. Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651 [TBL] [Abstract][Full Text] [Related]
17. [The prognostic markers of survival and progression in HIV-1 infection. A study of CD4+ lymphocytes, antigen p24 and viral load during 3 years in a cohort of 251 patients]. Rubio Caballero M; Nogués Biau A; Falguera Sacrest M; Puig Ganau T; Lecha N; Rubio Rivas C An Med Interna; 2000 Oct; 17(10):533-7. PubMed ID: 11109648 [TBL] [Abstract][Full Text] [Related]
18. Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users. Rezza G; Titti F; Pezzotti P; Sernicola L; Lo Caputo S; Angarano G; Lazzarin A; Sinicco A; Rossi GB; Verani P J Biol Regul Homeost Agents; 1992; 6(1):15-20. PubMed ID: 1359736 [TBL] [Abstract][Full Text] [Related]
19. The predictive value of several markers in the progression to acquired immunodeficiency syndrome. Planella T; Cortés M; Martínez-Brú C; Barrio J; Sambeat MA; González-Sastre F Clin Chem Lab Med; 1998 Mar; 36(3):169-73. PubMed ID: 9589805 [TBL] [Abstract][Full Text] [Related]
20. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. Goedert JJ; Kessler CM; Aledort LM; Biggar RJ; Andes WA; White GC; Drummond JE; Vaidya K; Mann DL; Eyster ME N Engl J Med; 1989 Oct; 321(17):1141-8. PubMed ID: 2477702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]